RVMD (Revolution Medicines Inc) Stock Quotes

Brandmark of RevMed (RVMD)

Revolution Medicines (RVMD) focuses on developing targeted oncology treatments by inhibiting the RAS pathway to assist patients with limited options. As the business is currently in the development stage, its operations are independent of market cycles or seasonality, and the current metric stands at 166.71. The market price, as confirmed by the chart, complements data regarding the strict control of raw material supplies for biopharmaceutical testing.

Stock Quotes: Revolution Medicines Corp (RVMD) for 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for RevMed (RVMD)

- stock value and consensus price forecast:
Comprehensive company analysis:RVMD RevMed
Brand item of Revolution Medicines Inc

Price determines the asset's market capitalization, reflecting investors' aggregate valuation of future cash flows. This historical price chart visualizes the dynamics of capital reallocation within the biopharmaceutical sector. The metric aggregates all fundamental expectations and market demand into a single quote. For Revolution Medicines (RVMD), the share price depends directly on the effectiveness of R&D developments. Supply chain risks via CMO partners create volatility for this indicator.

Who Revolution Medicines competes with

Price Chart BeiGene Oncology (ONC)|HALO (Halozyme) - Price Performance Chart|Stock Price AAPG (Ascentage Pharma Group International)|Price Rate Chart CG Oncology Therapeutics|UroGen Pharma Corp - Stock Price|BCAX - Stock Price|Personalis (PSNL) - Price Chart|ERAS - Market Chart|DCTH (Delcath Corp) - Stock Price|Stock Quotes YmAbs (YMAB)|Stock Price AURA|Stock Price Candel Therapeutics Inc. (CADL)|Price Chart Accuray Inc. ARAY|SLS - Stock Quotes|Actuate Therapeutics Inc - Stock Price|Citius Oncology, Inc (CTOR) - Stock Quotes|HURA: Stock Price|Market Price protaratx.com (TARA)|Price Chart Fate Therapeutics|WHWK: Price Performance Chart|Stock Quotes TCRX (TScan Therapeutics Inc)|CSBR (Champions Oncology, Inc.) - Price Performance Chart|Stock Price XBIT (XBiotech Inc.)|Stock Price CEL-SCI Corporation CVM|OSTX: Stock Quotes|RADX - Stock Price|Artiva (ARTV) - Price Chart|Market Price Adlai Nortye Ltd (ANL)|VERU (Veru Inc) - Stock Price|Market Price Tempest Therapeutics, Inc. TPST|Stock Price XLO|RENB (Renovaro) - Price Performance Chart|Mural Oncology PLC - Stock Quotes|Stock Price Kairos Pharma Inc KAPA|OKUR - Price Chart|CytoMed Therapeutics Limited - Price|CRIS: Stock Price|APLM (Apollomics Corp) - Price Chart|THAR (Tharimmune Corporation) - Stock Price|Share Price ADVB (Advanced Biomed Inc)|Stock Price GNPX|Market Chart Calidi Bio|Price Chart Sunshine Biopharma, Inc. SBFM|XBIO - Stock Quotes|SLRX - Price Chart|PPBT: Price Chart|AONC (AON) - Stock Quotes|BGNE (BeiGene) - Price Chart|Stock Quotes CKPT|ELEV: Price Performance Chart|Stock Price ICAD|Price Chart IKNA (Ikena Oncology Inc.)|Price Chart notablelabs.com NTBL|Price Performance Chart VIRX|MOR - Price Chart|NAYA (NAYA Biosciences Inc.) - Share Price|AAPGV: Stock Price